Correlation Between BioAffinity Technologies, and Ovid Therapeutics
Can any of the company-specific risk be diversified away by investing in both BioAffinity Technologies, and Ovid Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioAffinity Technologies, and Ovid Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between bioAffinity Technologies, and Ovid Therapeutics, you can compare the effects of market volatilities on BioAffinity Technologies, and Ovid Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioAffinity Technologies, with a short position of Ovid Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioAffinity Technologies, and Ovid Therapeutics.
Diversification Opportunities for BioAffinity Technologies, and Ovid Therapeutics
0.1 | Correlation Coefficient |
Average diversification
The 3 months correlation between BioAffinity and Ovid is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding bioAffinity Technologies, and Ovid Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ovid Therapeutics and BioAffinity Technologies, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on bioAffinity Technologies, are associated (or correlated) with Ovid Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ovid Therapeutics has no effect on the direction of BioAffinity Technologies, i.e., BioAffinity Technologies, and Ovid Therapeutics go up and down completely randomly.
Pair Corralation between BioAffinity Technologies, and Ovid Therapeutics
Given the investment horizon of 90 days bioAffinity Technologies, is expected to under-perform the Ovid Therapeutics. In addition to that, BioAffinity Technologies, is 1.25 times more volatile than Ovid Therapeutics. It trades about -0.45 of its total potential returns per unit of risk. Ovid Therapeutics is currently generating about -0.4 per unit of volatility. If you would invest 95.00 in Ovid Therapeutics on October 23, 2024 and sell it today you would lose (21.00) from holding Ovid Therapeutics or give up 22.11% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
bioAffinity Technologies, vs. Ovid Therapeutics
Performance |
| Timeline |
| bioAffinity Technologies, |
| Ovid Therapeutics |
BioAffinity Technologies, and Ovid Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with BioAffinity Technologies, and Ovid Therapeutics
The main advantage of trading using opposite BioAffinity Technologies, and Ovid Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioAffinity Technologies, position performs unexpectedly, Ovid Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ovid Therapeutics will offset losses from the drop in Ovid Therapeutics' long position.| BioAffinity Technologies, vs. Nuvalent | BioAffinity Technologies, vs. Arcellx | BioAffinity Technologies, vs. Vaxcyte | BioAffinity Technologies, vs. Crinetics Pharmaceuticals |
| Ovid Therapeutics vs. CytomX Therapeutics | Ovid Therapeutics vs. Spero Therapeutics | Ovid Therapeutics vs. Instil Bio | Ovid Therapeutics vs. NextCure |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |